Sign in

CIK 0001727196

  • Non-accelerated filer

Scholar Rock Holding Corp

Sign in to watch
Ticker
SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823750435
Phone
+1 857-259-3860
Business address
301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$11,999,922
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. AKKARAJU SRINIVAS +$12.0M Director 1 filing

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-12 Qatanani Mo CHIEF SCIENTIFIC OFFICER Grant or award · Stock Option (Right to Buy) +94,285 94,285
2024-02-12 Parlavecchio Caryn CHRO Grant or award +47,145 161,495
2024-02-12 Parlavecchio Caryn CHRO Grant or award · Stock Option (Right to Buy) +62,855 62,855
2024-02-12 Myles Edward H COO & CFO Grant or award +53,570 215,720
2024-02-12 Myles Edward H COO & CFO Grant or award · Stock Option (Right to Buy) +71,430 71,430
2024-02-12 Ho Junlin GENERAL COUNSEL Grant or award +57,855 212,260
2024-02-12 Ho Junlin GENERAL COUNSEL Grant or award · Stock Option (Right to Buy) +77,145 77,145
2024-01-16 Qatanani Mo SVP AND HEAD OF RESEARCH Sale −2,002 $15.93 $32K 78,816
2024-01-16 Parlavecchio Caryn CHRO Sale −2,849 $15.93 $45K 114,350
2024-01-16 Myles Edward H COO & CFO Sale −6,634 $15.93 $106K 162,150
2024-01-16 Ho Junlin GENERAL COUNSEL Sale −4,186 $15.93 $67K 154,405
2023-12-29 Myles Edward H COO & CFO Exercise or conversion 10b5-1 +12,459 $4.86 $61K 181,243
2023-12-29 Myles Edward H COO & CFO Sale 10b5-1 −12,159 $18.82 $229K 169,084
2023-12-29 Myles Edward H COO & CFO Sale 10b5-1 −300 $19.51 $6K 168,784
2023-12-29 Myles Edward H COO & CFO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −24,914 49,836
2023-12-27 Nashat Amir Director Gift −21,333 25,506
2023-12-21 Burow Kristina Director Other disposition −291,906 2,345,711
2023-12-21 Burow Kristina Director Other acquisition +5,339 5,339
2023-12-14 Qatanani Mo SVP AND HEAD OF RESEARCH Exercise or conversion +8,437 $10.00 $84K 105,480
2023-12-14 Qatanani Mo SVP AND HEAD OF RESEARCH Sale −24,662 $18.18 $448K 80,818

Page 17 of 22 · 422 trades